Stay updated on Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page
- Check3 days agoChange DetectedThe footer now identifies the site revision as v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check10 days agoChange DetectedThe record describes a completed Phase 3 study of ledipasvir/sofosbuvir for people with chronic genotype 1 hepatitis C, with study design, participant criteria, locations, and efficacy and safety outcomes. It also includes results-related publications and information about sharing participant data.SummaryDifference51%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appeared, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check45 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error, showing a minimal error page with the text '403 Forbidden' and a Home button, indicating the study record content is unavailable.SummaryDifference15%

Stay in the know with updates to Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.